
Elevation Oncology, Inc.
NASDAQ:ELEV
0.5108 (USD) • At close March 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -44.485 | -45.704 | -95.08 | -32.039 | -17.265 | -5.882 |
Depreciation & Amortization
| 0.024 | 0.039 | 0.027 | 0.018 | 0.015 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | -1.637 | 5.137 | 0 |
Stock Based Compensation
| 4.28 | 3.335 | 3.206 | 1.571 | 0.052 | 0.014 |
Change In Working Capital
| 3.839 | -13.69 | 6.29 | 0.283 | 4.9 | 0.423 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 0.052 | -5.855 | 0.711 | -0.03 | 5.219 | 0.46 |
Other Working Capital
| 3.787 | -7.835 | 5.579 | 0.313 | -0.319 | -0.037 |
Other Non Cash Items
| -0.022 | -0.16 | 0.074 | 1.637 | -5.137 | -0.451 |
Operating Cash Flow
| -36.364 | -56.18 | -85.483 | -30.167 | -12.298 | -5.45 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| 0 | 0 | -0.086 | 0 | -0.071 | 0 |
Acquisitions Net
| 0 | 0 | 0.044 | 0 | 0 | 0 |
Purchases Of Investments
| -69.565 | -42.657 | -112.312 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 61.2 | 54.2 | 68 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | -0.044 | 0 | 0 | 0 |
Investing Cash Flow
| -8.365 | 11.543 | -44.398 | 0 | -0.071 | 0 |
Financing Activities: | ||||||
Debt Repayment
| 0 | 0 | 30 | 0 | 0 | 0 |
Common Stock Issued
| 44.207 | 46.503 | 0 | 97.062 | 0.02 | 7.19 |
Common Stock Repurchased
| -0.048 | -0.024 | -0.035 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.779 | 1.496 | -0.451 | -0.011 | 90.009 | 10.785 |
Financing Cash Flow
| 44.938 | 47.975 | 29.514 | 97.051 | 90.029 | 7.19 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 0.209 | 3.338 | -100.367 | 66.884 | 77.66 | 1.74 |
Cash At End Of Period
| 49.464 | 49.255 | 45.917 | 146.284 | 79.4 | 1.74 |